Article Information
History
- June 25, 2023.
Article Versions
- Version 1 (July 3, 2021 - 18:30).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Yong Xiang1,
- Jinghong Qiu1,
- Ruoyu Zhang1,
- Carlos Kwan-Long Chau1,
- Shitao Rao8,1,2 and
- Hon-Cheong So1,7,*
- 1School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong
- 2CUHK Shenzhen Research Institute, Shenzhen, China
- 3KIZ-CUHK Joint Laboratory of Bioresources and Molecular Research of Common Diseases, Kunming Institute of Zoology and The Chinese University of Hong Kong, China
- 4Department of Psychiatry, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong
- 5Margaret K.L. Cheung Research Centre for Management of Parkinsonism, The Chinese University of Hong Kong, Shatin, Hong Kong
- 6Brain and Mind Institute, The Chinese University of Hong Kong, Shatin, Hong Kong
- 7Hong Kong Branch of the Chinese Academy of Sciences Center for Excellence in Animal Evolution and Genetics, The Chinese University of Hong Kong, Hong Kong SAR, China
- 8Department of Bioinformatics, Fujian Medical University, Fuzhou, China
- ↵*Correspondence to: Hon-Cheong So
, Lo Kwee-Seong Integrated Biomedical Sciences Building, The Chinese University of Hong Kong, Shatin, Hong Kong. Tel: +852 3943 9255; E-mail: hcso{at}cuhk.edu.hk
Posted June 25, 2023.
Neuropsychiatric disorders as risk factors and consequences of COVID-19: A Mendelian randomization study
